Vertex Pharmaceuticals VRTX
1,014 filings, 11 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Sep 1, 2026 CEO, CFO, COO or CAOCFO change “On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).” 8-K item 5.02 · all documents
- Feb 10, 2025 CEO, CFO, COO or CAOCFO and COO change “Wagner, Jr. as Chief Operating Officer of the Company and the appointment of Duncan J.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 112 events
- Nov 12, 2026 Planned sale WAGNER CHARLES F JR (Officer) gave notice of a planned sale of 15,286 shares worth about $8.4MForm 144, approximate sale date Nov 12, 2026, under a 10b5-1 plan adopted Aug 10, 2026
- Nov 6, 2026 Planned sale Kewalramani Reshma (Officer, Director) gave notice of a planned sale of 11,866 shares worth about $6.3MForm 144, approximate sale date Nov 6, 2026, under a 10b5-1 plan adopted Aug 5, 2026
- Nov 3, 2026 Planned sale Jeffrey Leiden (Executive Chairman) adopted a 10b5-1 trading planreported in the 10-Q, up to 18,411 shares, runs to Nov 4, 2027
- Nov 3, 2026 Planned sale Reshma Kewalramani (Chief Executive Officer and President, Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 47,800 shares, runs to Dec 1, 2027
- Nov 3, 2026 Planned sale Carmen Bozic (EVP, Global Medicines Development and Medical Affairs, and Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 16,915 shares, runs to Jul 30, 2027
- Nov 3, 2026 Planned sale Kristen Ambrose (SVP, Chief Accounting Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,422 shares, runs to Apr 30, 2027
- Nov 3, 2026 Planned sale Charles F. Wagner, Jr. (EVP, Chief Operating & Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,286 shares, runs to Jul 30, 2027
- Nov 3, 2026 Planned sale Sangeeta Bhatia (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,189 shares, runs to Jul 30, 2027
- Nov 3, 2026 Planned sale Nancy Thornberry (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 2,571 shares, runs to Jul 30, 2027
- Nov 3, 2026 Planned sale Joy Liu (EVP, Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 20,764 shares, runs to May 3, 2027
- Nov 3, 2026 Planned sale Bruce Sachs (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 9,888 shares, runs to Jul 20, 2027
- Nov 3, 2026 Planned sale Alan Garber (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 5,320 shares, runs to Jul 30, 2027
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Nov 2, 2026 8-K Quarterly results8-K item 2.02
- Oct 20, 2026 8-K Director or officer change8-K item 5.02
- Sep 1, 2026 Officer CFO changeOn August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).
- Aug 27, 2026 Planned sale Bruce I. Sachs (Director) gave notice of a planned sale of 1,210 shares worth about $663KForm 144, approximate sale date Aug 27, 2026
- Aug 4, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Aug 3, 2026 8-K Quarterly results8-K item 2.02
- Jul 7, 2026 8-K Material agreement signed, Regulation FD disclosure, Other events8-K items 1.01, 7.01, 8.01
- Jul 2, 2026 Planned sale McKechnie Duncan (Officer) gave notice of a planned sale of 1,541 shares worth about $800KForm 144, approximate sale date Jul 2, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Jul 2, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 1,500 shares worth about $787KForm 144, approximate sale date Jul 2, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Jul 1, 2026 Planned sale Liu Joy (Officer) gave notice of a planned sale of 828 shares worth about $416KForm 144, approximate sale date Jul 1, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Jun 26, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 596 shares worth about $288KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Jun 18, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 1,020 shares worth about $471KForm 144, approximate sale date Jun 18, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Jun 15, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 4,062 shares worth about $1.8MForm 144, approximate sale date Jun 15, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Jun 5, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 1,745 shares worth about $785KForm 144, approximate sale date Jun 5, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Jun 1, 2026 Planned sale Liu Joy (Officer) gave notice of a planned sale of 828 shares worth about $364KForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- May 29, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 1,974 shares worth about $888KForm 144, approximate sale date May 29, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- May 15, 2026 Planned sale Bunnage Mark E. (Officer) gave notice of a planned sale of 33 shares worth about $15KForm 144, approximate sale date May 15, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- May 15, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 1,354 shares worth about $614KForm 144, approximate sale date May 15, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- May 13, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 12, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 6,988 shares worth about $3.1MForm 144, approximate sale date May 12, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- May 6, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 5,193 shares worth about $2.2MForm 144, approximate sale date May 6, 2026
- May 5, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- May 4, 2026 Planned sale Bhatia Sangeeta N. (Director) gave notice of a planned sale of 318 shares worth about $135KForm 144, approximate sale date May 4, 2026, under a 10b5-1 plan adopted May 27, 2025
- May 4, 2026 8-K Quarterly results8-K item 2.02
- May 1, 2026 Planned sale Liu Joy (Officer) gave notice of a planned sale of 1,104 shares worth about $469KForm 144, approximate sale date May 1, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Apr 29, 2026 8-K Director or officer change8-K item 5.02
- Apr 14, 2026 SEC letter SEC asked 1 question about Form 10-Kletters Mar 18, 2026 to Apr 14, 2026
- Apr 1, 2026 Planned sale Liu Joy (Officer) gave notice of a planned sale of 978 shares worth about $439KForm 144, approximate sale date Apr 1, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 31, 2026 8-K Other events8-K item 8.01
- Mar 27, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 2,329 shares worth about $1.1MForm 144, approximate sale date Mar 27, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Mar 13, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 2,329 shares worth about $1.1MForm 144, approximate sale date Mar 13, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Mar 11, 2026 Planned sale McKechnie Duncan (Officer) gave notice of a planned sale of 2,633 shares worth about $1.3MForm 144, approximate sale date Mar 11, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 4, 2026 Planned sale McKechnie Duncan (Officer) gave notice of a planned sale of 2,437 shares worth about $1.2MForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Mar 2, 2026 Planned sale Liu Joy (Officer) gave notice of a planned sale of 892 shares worth about $442KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Feb 27, 2026 Planned sale Bozic Carmen (Officer) gave notice of a planned sale of 2,329 shares worth about $1.1MForm 144, approximate sale date Feb 27, 2026, under a 10b5-1 plan adopted Nov 20, 2025
- Feb 27, 2026 Planned sale Kewalramani Reshma (Officer, Director) gave notice of a planned sale of 40,000 shares worth about $19.7MForm 144, approximate sale date Feb 27, 2026, under a 10b5-1 plan adopted Nov 17, 2025
- Feb 25, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 945 shares worth about $460KForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Feb 24, 2025
- Feb 25, 2026 Planned sale Sachdev Amit (Officer) gave notice of a planned sale of 1,846 shares worth about $898KForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Nov 18, 2025
- Feb 25, 2026 Planned sale Atkinson Edward Morrow III (Officer) gave notice of a planned sale of 668 shares worth about $325KForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Feb 25, 2026 Planned sale Bunnage Mark E. (Officer) gave notice of a planned sale of 620 shares worth about $302KForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Feb 25, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 260 shares worth about $126KForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Feb 25, 2026 Planned sale McKechnie Duncan (Officer) gave notice of a planned sale of 4,910 shares worth about $2.4MForm 144, approximate sale date Feb 25, 2026, under a 10b5-1 plan adopted Nov 25, 2025
- Feb 19, 2026 Planned sale Sachdev Amit (Officer) gave notice of a planned sale of 58,613 shares worth about $27.5MForm 144, approximate sale date Feb 19, 2026, under a 10b5-1 plan adopted Nov 18, 2025
- Feb 18, 2026 Planned sale Atkinson Edward Morrow III (Officer) gave notice of a planned sale of 817 shares worth about $387KForm 144, approximate sale date Feb 18, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Feb 18, 2026 Planned sale Bunnage Mark E. (Officer) gave notice of a planned sale of 1,182 shares worth about $560KForm 144, approximate sale date Feb 18, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Feb 18, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 1,244 shares worth about $589KForm 144, approximate sale date Feb 18, 2026, under a 10b5-1 plan adopted Feb 24, 2025
- Feb 18, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 368 shares worth about $174KForm 144, approximate sale date Feb 18, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Feb 17, 2026 Planned sale Atkinson Edward Morrow III (Officer) gave notice of a planned sale of 2,031 shares worth about $994KForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Feb 17, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 2,476 shares worth about $1.2MForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Feb 24, 2025
- Feb 17, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 609 shares worth about $298KForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Feb 17, 2026 Planned sale Bunnage Mark E. (Officer) gave notice of a planned sale of 2,437 shares worth about $1.2MForm 144, approximate sale date Feb 17, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Feb 13, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 1,500 shares worth about $750KForm 144, approximate sale date Feb 13, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Feb 13, 2026 Planned sale Bhatia Sangeeta N. (Director) gave notice of a planned sale of 266 shares worth about $133KForm 144, approximate sale date Feb 13, 2026, under a 10b5-1 plan adopted May 27, 2025
- Feb 13, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 988 shares worth about $493KForm 144, approximate sale date Feb 13, 2026, under a 10b5-1 plan adopted Feb 24, 2025
- Feb 13, 2026 Planned sale Reshma Kewalramani (Chief Executive Officer and President) adopted a 10b5-1 trading planreported in the 10-K, up to 40,000 shares, runs to Nov 16, 2026
- Feb 13, 2026 Planned sale Amit Sachdev (EVP, Chief Patient and External Affairs Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 70,498 shares, runs to Oct 30, 2026
- Feb 13, 2026 Planned sale Carmen Bozic (EVP, Global Medicines Development and Medical Affairs, Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 34,733 shares, runs to Nov 2, 2026
- Feb 13, 2026 Planned sale Duncan McKechnie (EVP, Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 17,367 shares, runs to Nov 13, 2026
- Feb 13, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 12, 2026 8-K Quarterly results8-K item 2.02
- Feb 11, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 466 shares worth about $215KForm 144, approximate sale date Feb 11, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Feb 11, 2026 Planned sale Bunnage Mark E. (Officer) gave notice of a planned sale of 2,021 shares worth about $931KForm 144, approximate sale date Feb 11, 2026, under a 10b5-1 plan adopted Nov 26, 2025
- Feb 11, 2026 Planned sale Atkinson Edward Morrow III (Officer) gave notice of a planned sale of 1,751 shares worth about $806KForm 144, approximate sale date Feb 11, 2026, under a 10b5-1 plan adopted Aug 11, 2025
- Feb 11, 2026 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 1,925 shares worth about $886KForm 144, approximate sale date Feb 11, 2026, under a 10b5-1 plan adopted Feb 24, 2025
- Jan 7, 2026 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 4,500 shares worth about $2.1MForm 144, approximate sale date Jan 7, 2026, under a 10b5-1 plan adopted Aug 21, 2025
- Jan 6, 2026 Planned sale WAGNER CHARLES F JR (Officer) gave notice of a planned sale of 9,532 shares worth about $4.4MForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted May 9, 2025
- Dec 3, 2025 Planned sale Biller Jonathan (Officer) gave notice of a planned sale of 347 shares worth about $156KForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted Feb 24, 2025
- Dec 3, 2025 Planned sale Tatsis Ourania (Officer) gave notice of a planned sale of 4,500 shares worth about $2.0MForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted Aug 21, 2025
- Dec 3, 2025 Planned sale WAGNER CHARLES F JR (Officer) gave notice of a planned sale of 7,000 shares worth about $3.2MForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted May 9, 2025
- Dec 3, 2025 Planned sale WAGNER CHARLES F JR (Officer) gave notice of a planned sale of 7,000 shares worth about $3.2MForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted May 9, 2025
- Dec 3, 2025 Planned sale JEFFREY M LEIDEN (Director, Officer) gave notice of a planned sale of 63,781 shares worth about $27.6MForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted Aug 6, 2025
- Nov 20, 2025 Planned sale CARNEY LLOYD (Director) gave notice of a planned sale of 800 shares worth about $341KForm 144, approximate sale date Nov 20, 2025
- Nov 17, 2025 Planned sale Atkinson Edward Morrow III (Officer) gave notice of a planned sale of 2,500 shares worth about $1.1MForm 144, approximate sale date Nov 17, 2025, under a 10b5-1 plan adopted Aug 11, 2025
- Nov 14, 2025 Planned sale JEFFREY M LEIDEN (Director, Officer) gave notice of a planned sale of 53,604 shares worth about $23.3MForm 144, approximate sale date Nov 14, 2025, under a 10b5-1 plan adopted Aug 6, 2025
- Nov 13, 2025 Planned sale JEFFREY M LEIDEN (Director, Officer) gave notice of a planned sale of 19,688 shares worth about $8.5MForm 144, approximate sale date Nov 13, 2025, under a 10b5-1 plan adopted Aug 6, 2025
- Nov 4, 2025 Planned sale Carmen Bozic (EVP, Global Medicines Development and Medical Affairs, Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 19,404 shares, runs to Nov 21, 2025
- Nov 4, 2025 Planned sale Jeffrey Leiden (Executive Chairman) adopted a 10b5-1 trading planreported in the 10-Q, up to 144,644 shares, runs to Jan 21, 2026
- Nov 4, 2025 Planned sale Kristen Ambrose (SVP, Chief Accounting Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,539 shares, runs to Aug 3, 2026
- Nov 4, 2025 Planned sale E. Morrow "Morrey" Atkinson, III (EVP, Chief Technical Operations Officer, Head of Biopharmaceuitcal Sciences and Manufacturing Operations) adopted a 10b5-1 trading planreported in the 10-Q, up to 12,709 shares, runs to Apr 30, 2026
- Nov 4, 2025 Planned sale Ourania "Nia" Tatsis (EVP, Chief Regulatory and Quality Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 24,301 shares, runs to Jul 31, 2026
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Nov 3, 2025 8-K Quarterly results8-K item 2.02
- Aug 5, 2025 Planned sale Charles F. Wagner, Jr. (EVP, Chief Operating & Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 23,532 shares, runs to Feb 6, 2026
- Aug 5, 2025 Planned sale Sangeeta Bhatia (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,116 shares, runs to May 8, 2026
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Aug 4, 2025 8-K Quarterly results, Director or officer change8-K items 2.02, 5.02
- May 19, 2025 8-K Other events8-K item 8.01
- May 14, 2025 8-K Shareholder vote results8-K item 5.07
- May 7, 2025 SEC letter SEC asked 1 question about Form 10-Kletters Apr 7, 2025 to May 7, 2025 · Results discussion (MD&A)
- May 6, 2025 Planned sale Amit Sachdev (EVP, Chief Patient and External Affairs Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 48,505 shares, runs to Jan 30, 2026
- May 6, 2025 Planned sale Jonathan Biller (EVP, Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 22,217 shares, runs to Feb 27, 2026
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- May 5, 2025 8-K Quarterly results8-K item 2.02
- Mar 28, 2025 8-K Other events8-K item 8.01
- Feb 13, 2025 Planned sale Ourania "Nia" Tatsis (EVP, Chief Regulatory and Quality Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 11,270 shares, runs to Oct 31, 2025
- Feb 13, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · Under this process, we may sell from time to time any combination of the securities described in this prospectus.
- Feb 13, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 10, 2025 Officer CFO and COO changeWagner, Jr. as Chief Operating Officer of the Company and the appointment of Duncan J.
- Dec 20, 2024 8-K Regulation FD disclosure8-K item 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 2, 2026 | 8-K | Quarterly results |
| Oct 20, 2026 | 8-K | Director or officer change |
| Sep 1, 2026 | 8-K | Director or officer change |
| Aug 3, 2026 | 8-K | Quarterly results |
| Jul 7, 2026 | 8-K | Material agreement signed, Regulation FD disclosure, Other events |
| May 13, 2026 | 8-K | Director or officer change, Shareholder vote results |
| May 4, 2026 | 8-K | Quarterly results |
| Apr 29, 2026 | 8-K | Director or officer change |
| Mar 31, 2026 | 8-K | Other events |
| Feb 12, 2026 | 8-K | Quarterly results |
| Nov 3, 2025 | 8-K | Quarterly results |
| Aug 4, 2025 | 8-K | Quarterly results, Director or officer change |
| May 19, 2025 | 8-K | Other events |
| May 14, 2025 | 8-K | Shareholder vote results |
| May 5, 2025 | 8-K | Quarterly results |
| Mar 28, 2025 | 8-K | Other events |
| Feb 10, 2025 | 8-K | Quarterly results, Director or officer change |
| Dec 20, 2024 | 8-K | Regulation FD disclosure |
| Nov 4, 2024 | 8-K | Quarterly results |
| Aug 16, 2024 | 8-K | Material agreement signed |
| Aug 1, 2024 | 8-K | Quarterly results |
| Jun 27, 2024 | 8-K | Other events |
| May 20, 2024 | 8-K | Other events |
| May 15, 2024 | 8-K | Shareholder vote results |
| May 6, 2024 | 8-K | Quarterly results |
| Apr 11, 2024 | 8-K | Material agreement signed, Other events |
| Feb 5, 2024 | 8-K | Quarterly results |
| Dec 8, 2023 | 8-K | Other events |
| Dec 5, 2023 | 8-K | Director or officer change |
| Nov 6, 2023 | 8-K | Quarterly results |
| Oct 5, 2023 | 8-K | Director or officer change |
| Aug 1, 2023 | 8-K | Quarterly results |
| May 18, 2023 | 8-K | Shareholder vote results |
| May 1, 2023 | 8-K | Quarterly results |
| Feb 7, 2023 | 8-K | Quarterly results |
| Oct 27, 2022 | 8-K | Quarterly results |
| Aug 4, 2022 | 8-K | Quarterly results |
| Jul 11, 2022 | 8-K | Other events |
| Jul 5, 2022 | 8-K | Material agreement signed, Material agreement ended, New debt or obligation |
| May 23, 2022 | 8-K | Other events |
| May 18, 2022 | 8-K | Shareholder vote results |
| May 5, 2022 | 8-K | Quarterly results |
| Jan 26, 2022 | 8-K | Quarterly results |
| Nov 2, 2021 | 8-K | Quarterly results |
| Jul 29, 2021 | 8-K | Quarterly results |
| Jun 24, 2021 | 8-K | Other events |
| May 19, 2021 | 8-K | Shareholder vote results |
| Apr 29, 2021 | 8-K | Quarterly results |
| Apr 20, 2021 | 8-K | Material agreement signed |
| Feb 1, 2021 | 8-K | Quarterly results |
| Nov 20, 2020 | 8-K | Other events |
| Oct 29, 2020 | 8-K | Quarterly results |
| Sep 21, 2020 | 8-K | Material agreement signed, New debt or obligation |
| Jul 30, 2020 | 8-K | Quarterly results |
| Jun 3, 2020 | 8-K | Shareholder vote results |
Show the other 30 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VRTX/export.csv") into a cell.